{"id":"NCT00866697","sponsor":"Novartis Pharmaceuticals","briefTitle":"Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer","officialTitle":"A Phase III Study to Evaluate the Efficacy and Safety of Pazopanib Monotherapy Versus Placebo in Women Who Have Not Progressed After First Line Chemotherapy for Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-05-26","primaryCompletion":"2012-07-08","completion":"2017-08-24","firstPosted":"2009-03-20","resultsPosted":"2013-12-19","lastUpdate":"2021-02-16"},"enrollment":940,"design":{"allocation":"RANDOMIZED","model":null,"masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Ovarian Cancer"],"interventions":[{"type":"DRUG","name":"Pazopanib","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Pazopanib","type":"EXPERIMENTAL"}],"summary":"This was a study to determine whether therapy with pazopanib was effective and safe in women with epithelial ovarian, fallopian tube, or primary peritoneal cancer whose cancer had not progressed on first line chemotherapy.","primaryOutcome":{"measure":"Investigator-assessed Progression-free Survival (PFS)","timeFrame":"From the date of randomization until the date of progression or death due to any cause (median time of follow-up was 17.9 months for pazopanib and 12.3 months for placebo)","effectByArm":[{"arm":"Placebo","deltaMin":12.3,"sd":null},{"arm":"Pazopanib 800 mg","deltaMin":17.9,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0021"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":18,"exclusionCount":19},"locations":{"siteCount":318,"countries":["United States","Australia","Austria","Belgium","China","Denmark","France","Germany","Hong Kong","Ireland","Italy","Japan","Norway","South Korea","Spain","Sweden","Taiwan"]},"refs":{"pmids":["37185961","31519320","29267856","27769273","26588236","25434635","25225436"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":51,"n":461},"commonTop":["Hypertension","Diarrhoea","Nausea","Headache","Fatigue"]}}